SOURCE: Bryn Mawr Partners

November 28, 2005 12:37 ET

Bryn Mawr Partners Assists Global Life Sciences Firm

CHICAGO, IL -- (MARKET WIRE) -- November 28, 2005 -- Quality and regulatory systems consultant Bryn Mawr Partners announces it has successfully completed a fast-track engagement to assist a global life sciences firm in developing the parameters for a world-class quality management system. Before engaging Bryn Mawr Partners, the company's manufacturing sites and business units used a variety of different methods for managing nonconformities and corrective and preventive actions. These are quality-related manufacturing issues that are regulated by the FDA and other international agencies. Working with the engagement partner and key users and stakeholders throughout the company, Bryn Mawr Partners helped the manufacturer define a corporate-level business process in only four weeks. "The company needed to have universal definitions, codes, and quality standards across all sites," said Bryn Mawr Partners' senior partner Phillip Anuta. "But the sites manufacture different products, so there had to be some flexibility too. We showed them how they could have the best of both worlds."

Highly developed quality management systems and procedures are necessities in the heavily regulated life sciences industry. Most manufacturers need expert help to implement common processes and systems successfully throughout their vast operations. Bryn Mawr Partners is leading the way in this very specialized field. With a combined 68 years of experience, the principals of Bryn Mawr Partners are industry veterans who know first-hand how to navigate through difficult technical and procedural issues related to corrective and preventive action (CAPA) management, complaint management, and similar regulatory issues.

About Bryn Mawr Partners

Oakbrook Terrace, Illinois-based Bryn Mawr Partners is a privately held firm offering regulatory compliant quality management and e-submission systems-delivery solutions for life sciences organizations subject to regulatory scrutiny. Bryn Mawr Partners co-founders Mark Schaub, Phillip Anuta, and Paul Nowling are widely recognized for their extensive experience in global electronic regulatory compliance projects and software systems for pharmaceutical, medical device, and biotechnology environments. The firm works with all aspects of the delivery cycle (planning, development, testing, and deployment) of quality and regulatory management systems. They specialize in CAPA management, complaint handling, document management, and e-submission solutions. For more information, visit www.brynmawrpartners.com.

Contact Information

  • Contact:
    Jim Grosspietsch
    Director of Marketing
    Bryn Mawr Partners
    630-954-0890
    Email Contact